Ignite Creation Date:
2025-12-24 @ 12:15 PM
Ignite Modification Date:
2026-01-12 @ 5:20 PM
Study NCT ID:
NCT03933761
Status:
WITHDRAWN
Last Update Posted:
2021-08-10
First Post:
2019-04-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression on Substrate Poly ADP Ribose Polymerase Inhibitbor (PARPI) or Chemotherapy
Sponsor:
Australia New Zealand Gynaecological Oncology Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-29
Start Date Type:
ACTUAL
Primary Completion Date:
2021-08-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-08-02
Completion Date Type:
ACTUAL
First Submit Date:
2019-04-02
First Submit QC Date:
None
Study First Post Date:
2019-05-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-03
Last Update Post Date:
2021-08-10
Last Update Post Date Type:
ACTUAL